
SNP has left NHS fighting for its life as one in 10 operations are still being cancelled
Despite a pledge from John Swinney and his under-fire Health Secretary Neil Gray to 'renew' the NHS, new figures showed a decline in the number of planned operations in May compared to a year ago, while the number of them being cancelled has marginally increased.
It led to concerns about the impact cancellations have on the physical and mental health of patients.
Cases of patients being stuck in hospital because of bed-blocking were also similar in May compared to April, data from Public Health Scotland showed, sparking claims that the SNP Government has failed to deliver the improvements it has promised.
Scottish Conservative public health spokesman Brian Whittle said: 'These figures confirm that our NHS is dangerously flatlining under Neil Gray and John Swinney's disastrous stewardship.
'Having an operation cancelled at the last minute takes a huge toll on the physical and mental wellbeing of patients.
'The reason the number of cancelled operations remains so stubbornly high is almost two decades of SNP mismanagement. From years of shoddy workforce planning to the knock-on effects of their failure to eliminate bed-blocking, Scots are paying the price for Nationalist incompetence.'
The new Public Health Scotland figures showed that there were 25,067 operations planned to take place across the NHS in Scotland in May 2025, which was 311 lower than May 2024. The numbers had previously been steadily increasing since the coronavirus pandemic but 'began to plateau' from April 2024.
In the period from June 2024 to May 2025 there was a 0.6 per cent increase compared to the previous 12 month period, but this was 14.6 per cent lower than the last full pre-Covid year in 2018/19.
Public Health Scotland's report said: 'While a year-on-year increase is still being observed, the rate of growth has slowed.'
In May 2025, 2,019, or 8.1 per cent, of all planned operations were cancelled, compared to 2,018, or 8 per cent, in May 2024.
In three health boards, the rate of cancellations was well above one in ten, with 12.1 per cent in NHS Orkney, 10.5 per cent in NHS Dumfries and Galloway and 10.3 per cent in NHS Borders.
Of those appointments cancelled, 437 did not go ahead because of hospital capacity or other non-clinical reasons.
Scottish Labour health spokesman Jackie Baillie said: 'At a time when thousands of Scots are languishing on waiting lists waiting for treatment, it is a scandal that fewer operations are taking place.
'Far from tackling the crisis in our NHS, the SNP is fanning its flames.'
Figures also showed bed-blocking - where patients are medically well enough to be discharged but are stuck in hospital because they do not have a care home place or an agreed care plan - remains a significant strain on the NHS.
The number of these 'delayed discharge' cases was 1,840 in May 2025, compared to 1,868 in March 2025.
An average of 1,852 beds were occupied per day because of delayed discharge in May, which is only a marginal decline on 1,864 in April.
Dr Fiona Hunter, vice president of the Royal College of Emergency Medicine Scotland, said: 'Yet again, the evidence to address delayed discharges continues to mount. As I've said before, and I will say it again, the situation at our hospitals' 'backdoor', where we are unable to discharge people, is deeply concerning and distressing for both patients and the workforce.
'Patients when they are well enough to leave want to do just that - leave to continue their recovery. But often they can't because of a lack of social care.'
She said 'seriously unwell people' in A&E are often left on trolleys waiting for a care bed, and added: 'So it is hard to celebrate slight improvements in extreme waiting times when every day my colleagues are struggling to admit vulnerable patients that need further care.
'Until available inpatient bed numbers increase the crisis in our EDs will continue.'
Health Secretary Mr Gray said: 'Despite continued pressure on our health service it is encouraging to see an increase in the number of planned operations in the last year, compared to the previous twelve months.
'We are working closely with health boards across Scotland to maximise capacity and to ensure that any patients who have had their operations cancelled are seen as quickly as possible.
'Through an additional £200 million investment contained in the Budget to reduce waiting times and improve flow through hospital, we are creating extra appointments and procedures while making greater use of regional and national working.'
On delayed discharge, he said: 'Alongside recent improvements in A&E waiting times, this latest data shows our efforts are working and our plan is delivering results.
'But we want to drive further improvements, which is why we are investing £200 million through our Budget to reduce waiting lists, expand capacity, and remove the barriers that keep patients in hospital longer than necessary - backed by a record £21 billion investment for Health and Social Care.'

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Daily Mail
35 minutes ago
- Daily Mail
BREAKING NEWS Urgent recall for life-saving device over dangerous defect
An entire line of defibrillators has been urgently recalled after issues with the devices' circuits caused some of them to fail. The federal government issued a notice for medical technology firm Stryker's HeartSine samaritan Public Access Defibrillator (PAD) on June 24. 'A manufacturing problem related to a circuit board component may impair the device's ability to function or cause failure,' it said. 'This failure could occur at any point when the device is holding a charge. This may be in preparation to deliver therapy, while delivering a shock, or after shock delivery. 'The device becomes inoperable after the failure occurs.' The notice said the defect was spotted during quality testing, not patient use. The source of the issue was the Pad-Pak, a single-use battery and electrode cartridge containing the battery to power the defibrillator and two electrode pads. Users should check their AED serial number to see if it is affected, noting the devices are part of a subset of HeartSine samaritan PAD Models 350P, 360P, 450P and 500P. The affected devices are part of a subset of serial numbers beginning with 21, 22, 23 or 24, and are then followed by the letter B, D, E, G or H. Stryker said users should continue monitoring their PAD device to ensure the status indicator is flashing green every five to 10 seconds. They should contact Stryker immediately if the status indicator is flashing red, or they can hear continuous beeping or the voice prompt 'Warning, Low Battery'. Alternatively, they should contact the company if no status indicator is displayed. For further information, Stryker can be reached on 02 9170 9131 or through email at

Rhyl Journal
an hour ago
- Rhyl Journal
Breast cancer patients ‘denied life-extending drugs because of unfair system'
Breast Cancer Now has demanded 'immediate action' from Health Secretary Wes Streeting, urging him to scrap spending restraints. It is also calling for the NHS spending watchdog the National Institute for Health and Care Excellence (Nice) to lower the bar for what it classes as a very severe health condition. Nice's severity modifier, introduced in 2022, gives treatment for more severe illnesses more weight, meaning the health benefits of certain drugs are valued more highly and more likely to be recommended for NHS use. According to Nice, the process raises the threshold for what it considers to be a cost-effective treatment, meaning it can give more expensive drugs the green light. However, a new report from Breast Cancer Now claims the system means women with incurable breast cancer with months to live may be told their condition does not qualify for the most severe rating. The call comes after it emerged that the life-extending drug Enhertu will not be made available for women with incurable breast cancer on the NHS in England and Wales. In November, Nice said talks with manufacturers AstraZeneca and Daiichi Sankyo over the price of the medication had broken down for the third time with no agreement. Claire Rowney, chief executive at Breast Cancer Now, said: 'The terrifying reality is that unless urgent action is taken thousands of women in the UK with incurable secondary breast cancer could be denied access to vital life-extending treatments because of an unfair system. 'We're talking about patients missing out on access to cutting-edge, effective treatments that could give them more time to be there for special moments such as birthdays or seeing their children or grandchildren start school. 'Treatments, such as Enhertu, that patients in other countries, including Scotland, can access, giving them the chance to live longer. 'Women with secondary breast cancer tell us they feel their lives are being deprioritised by the changes to the system. 'We will not stand by and witness more drugs being rejected or not taken forward, when the devastating cost is thousands more people with secondary breast cancer across England, Wales and Northern Ireland having their lives cut short.' Paula Van Santen, 50, was diagnosed with secondary breast cancer in July 2022, two months after her diagnosis of primary breast cancer. The mother-of-three, from Banbury in Oxfordshire, said: 'Secondary breast cancer has changed the lives of both myself and my family beyond belief. Coming to terms with my diagnosis is the hardest part because I've had to grieve for the life I had, but also the life that I'm not going to have. 'If a new drug can give me another six months, if it gives me another year, it's worth it. 'It could allow me to see my daughter get to 21, see my children get married or meet grandchildren. Just to have a picture with a grandchild so they would know that I existed would be so precious. That's what this could give.' Ms Rowney called for 'change' and said Mr Streeting should scrap 'opportunity-cost neutral' restraints. Opportunity cost neutrality in the Nice severity modifier aims to ensure the new system does not require more or less overall NHS funding than the old one. According to the Breast Cancer Now report, this is 'at the root of the issues with the modifier'. It added: 'It pits end-of-life cancer treatments against other severe conditions like cystic fibrosis in a way that's reductive and unfair to patients. And, ultimately, it creates barriers to the approval of drugs for advanced cancers.' Ms Rowney said: 'The system for deciding whether drugs are approved for use on the NHS must change now. 'We're calling for immediate action from Wes Streeting, Secretary of State for Health and Social Care, to urgently scrap 'opportunity-cost neutral' restraints and for Nice to lower the bar for what it defines as 'a severe condition'. And we stand ready to work with them.' Dr Samantha Roberts, chief executive of Nice, welcomed the report from Breast Cancer Now, saying: 'The independent analysis we commissioned recently showed the new severity weighting is working as intended and expected. 'It is able to be applied more widely – for example to treatments for cystic fibrosis, hepatitis D and Duchenne muscular dystrophy – and has contributed to an increase in positive decisions for cancer medicines and non-cancer medicines. 'And other breast cancer treatments have been recommended since we introduced the severity modifier – including for advanced breast cancer. 'We remain deeply disappointed that we were unable to recommend Enhertu for HER2-low advanced breast cancer. We know this was devastating to all those hoping for a different answer. 'It remains the only breast cancer treatment we have been unable to recommend in seven years.' A Department of Health and Social Care spokesperson said the upcoming 10-year health plan will 'transform the NHS and improve care for those facing cancer'. 'This includes rolling out DIY screening kits for cervical cancer, more radiotherapy machines in every region and opening more Community Diagnostic Centres closer to where people live,' they added. 'We know how disappointing it is to many families that the manufacturers of Enhertu are unwilling to sell this life-extending treatment to the NHS at a fair and reasonable price. Our door remains open to supporting the introduction of medicines at a cost-effective price.'


North Wales Chronicle
an hour ago
- North Wales Chronicle
Record number of NHS operations given in private hospitals
Data from the Independent Healthcare Providers Network (IHPN) show that private hospitals delivered the equivalent of 2,859 NHS procedures every working day in April – an increase of over 60% compared to the same month in 2019. It said that almost one in five NHS operations in England are carried out in private hospitals and clinics. Overall, the independent sector is delivering 10% of all NHS planned care, up from 8% before the Covid-19 pandemic, the IHPN said. The IHPN also said that the number of referrals it had received has also reached a record high – with private providers receiving 7,162 referrals each working day in April. Official NHS data show that the waiting list for routine hospital treatment in England has fallen to its lowest level for two years. An estimated 7.39 million treatments were waiting to be carried out at the end of April, relating to 6.23 million patients – down from 7.42 million treatments and 6.25 million patients at the end of March. The Government has set out plans to send more patients for treatment in private hospitals to slash waiting lists. David Hare, chief executive of the IHPN, said: 'This latest data shows the independent sector's increasingly pivotal role in delivering frontline NHS care – delivering record levels of NHS care which will be instrumental in helping the Government to meet their key milestone to ensure 92% of patients are treated within 18 weeks by the end of this Parliament. 'While this is a clear sign of welcome progress in tackling NHS waiting lists, the sector is committed to building on this already impressive achievement and will be working with the Government to ensure the principles contained in the recent NHS and Independent Sector Partnership Agreement are fully embedded – enabling patients to have a greater choice over their care so they can get the treatment they need, when they need it.'